Search Results
Oct 31, 2025, 16:01 ET AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND
a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best
More news about: Amgen
Oct 31, 2025, 13:51 ET Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy
biotechnology industries, all of whom share the goal of translating research findings into safe and effective therapeutic interventions for all common and rare diseases.
More news about: Broad Institute
Oct 31, 2025, 13:22 ET Templeton Brings It Home: First Single Barrel Rye Crafted in Iowa from Grain to Glass
embodies our spirit of innovation while honoring our rich heritage, setting a new benchmark for excellence in American whiskey. Every pour offers a rare and remarkable expression of character and craft - no two barrels alike, each with its own distinct personality and complexity."
More news about: Infinium Spirits
Oct 31, 2025, 11:50 ET The Galien Foundation Honors Michael J. Fox and 2025 Prix Galien Award Recipients
Laureates—honored the 2025 Prix Galien Award winners in the categories of Best Biotechnology Product, Best Pharmaceutical Product, Best Product for Rare/Orphan Diseases, Best Medical Technology, Best Digital Health Solution, Incubators/Accelerators/Equity, Prix Galien EcoHealth, and Best Startup.
More news about: The Galien Foundation
Oct 31, 2025, 09:10 ET Abu Dhabi Royal Equestrian Arts, the World's Fifth School of Classical Horsemanship, Officially Opens Its Doors
housing thousands of rare texts and an archival collection of global significance. Visitors can explore the UAE's first bespoke saddle-making atelier, where historic craftsmanship is revived through a blend of artistry and heritage, as well as the Furusiyya Gallery, which features 173 rare artefacts dating
More news about: Abu Dhabi Royal Equestrian Arts (ADREA)
Oct 31, 2025, 09:04 ET Abu Dhabi Royal Equestrian Arts, the World's Fifth School of Classical Horsemanship, Officially Opens Its Doors
housing thousands of rare texts and an archival collection of global significance. Visitors can explore the UAE's first bespoke saddle-making atelier, where historic craftsmanship is revived through a blend of artistry and heritage, as well as the Furusiyya Gallery, which features 173 rare artefacts dating
More news about: Abu Dhabi Royal Equestrian Arts (ADREA)
Oct 31, 2025, 09:00 ET Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
the rate of muscle atrophy. The initiation of this Phase 2/3 clinical trial is a significant step for CB03-154 in the field of rare diseases, and it brought hopes to provide an important new treatment option for ALS patients. About Zhimeng
More news about: Shanghai Zhimeng Biopharma Inc.
Oct 31, 2025, 09:00 ET AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best
More news about: Amgen
Oct 31, 2025, 08:00 ET Ramaco Resources to Collaborate with Goldman Sachs on Strategic Initiative to Establish First National Critical Minerals Stockpile
our estimates of rare earth and critical minerals at the Brook Mine are reported as in-place inferred resources. Rare earth and critical minerals is a new initiative for us and, as such, has required and will continue to require us to make significant investments to build out our rare earth capabilities.
More news about: Ramaco Resources, Inc.
Oct 31, 2025, 08:00 ET Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
hospitalization.3 HRS is estimated to affect more than 60,000 Americans annually, approximately 0.01% of the U.S. population,4 making it a rare condition; and rates of HRS hospitalizations are increasing.5 Please see Limitation of Use and
More news about: Mallinckrodt plc
Oct 31, 2025, 08:00 ET PTC Therapeutics to Participate at Upcoming Investor Conferences
biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class
More news about: PTC Therapeutics, Inc.
Oct 31, 2025, 08:00 ET Servier's VORANIGO® (vorasidenib) Receives Prestigious 2025 Prix Galien USA Award
today announced that VORANIGO® (vorasidenib) has been awarded The Galien Foundation's 2025 Prix Galien USA Award for Best Product for Orphan/Rare Disease. The award was presented during a ceremony at the American Museum of Natural History in New York on October 30, 2025.
More news about: Servier Pharmaceuticals
Oct 31, 2025, 07:49 ET AbbVie Reports Third-Quarter 2025 Financial Results
(BPDCN). The submission is based on data from the Phase 1/2 CADENZA trial, a global study evaluating the safety and efficacy of PVEK in BPDCN. BPDCN is a rare and aggressive blood cancer with significant need for innovative treatment options for both newly diagnosed patients and for those whose prior treatments
More news about: AbbVie
Oct 31, 2025, 07:00 ET Marengo to Present Late-Breaking Clinical Oral Abstract at SITC 2025 Highlighting Initial Monotherapy Activity of Invikafusp Alfa in Tissue-Agnostic, TMB-High Advanced Cancers
preliminary efficacy of invikafusp alfa as a monotherapy in biomarker-selected patients with advanced antigen-rich solid tumors, including PD-1 refractory and rare tumor types. The trial consists of two parts: Phase 1 dose escalation and Phase 2 dose expansion. For more information, visit
More news about: Marengo Therapeutics
Oct 31, 2025, 06:42 ET Weekly Recap: 12 Tech Press Releases You Need to See
Nauticus Robotics Secures $250 Million Equity Facility and Launches Strategic Initiative to Enter Deep-Sea Rare Earth Mineral Exploration Market This new initiative is part of Nauticus' broader strategy
More news about: PR Newswire
Oct 31, 2025, 06:00 ET Oddities and Curiosities Expo Announces 2026 Tour Across U.S. and Canada
WHAT TO EXPECT Shop the strange: Attendees can browse and shop for rare and unique items, including taxidermy, preserved animal specimens, original horror and Halloween-inspired artwork, antiques, metaphysical accoutrements,
More news about: Oddities & Curiosities Expo
Oct 30, 2025, 23:11 ET Iozera Enters Agreement to Acquire Fully Operational Houston Data Center, Expanding AI-as-a-Service Infrastructure
with a dedicated, trained human workforce that supervises, labels, and refines every model in production. This "humans-in-the-loop" architecture is rare in modern AI infrastructure and ensures every deployment learns, adapts, and aligns in real time. Unlike
More news about: Iozera.ai
Oct 30, 2025, 20:00 ET CCTV4：The documentary Homeland Restored: 80 Years Since Taiwan's Recovery from Japanese Occupation is set to premiere
and abroad. As well as filming a wealth of invaluable historical relics, they also delved into archival documents, diaries, letters and obtained many rare video materials - many of which will be revealed to the public for the first time come the airing of the series. The documentary
More news about: CCTV4
Oct 30, 2025, 20:00 ET CCTV4：The documentary Homeland Restored: 80 Years Since Taiwan's Recovery from Japanese Occupation is set to premiere
and abroad. As well as filming a wealth of invaluable historical relics, they also delved into archival documents, diaries, letters and obtained many rare video materials - many of which will be revealed to the public for the first time come the airing of the series. The documentary
More news about: CCTV4
Oct 30, 2025, 18:34 ET Dr. Antoanella Calame Named "2025 Top Doctor"
sixth consecutive year that Dr. Calame has been recognized as a Top Doctor and notably, she is the only dermatopathologist to receive this honor. This rare distinction reflects her unwavering commitment to excellence in patient care, medical education, and diagnostic precision. For
More news about: Compass Dermatopathology
Oct 30, 2025, 17:31 ET Atypical Teratoid/Rhabdoid Tumor Treatment Market Shows Promising CAGR During the Forecast Period (2025-2034) with Growing Clinical Trials and R&D Initiatives | DelveInsight
The company is currently conducting Phase I dose-escalation trials to assess the safety and pharmacokinetics of ONC206 in patients with recurrent and rare primary central nervous system tumors, including atypical teratoid/rhabdoid tumors. In April 2025, Jazz Pharmaceuticals completed its acquisition of
More news about: DelveInsight Business Research, LLP
Oct 30, 2025, 17:15 ET Ramaco and U. S. Department of Energy's (DOE) National Energy Technology Laboratory (NETL) Execute Far-Reaching Strategic Agreement on Rare Earths and Critical Minerals
our estimates of rare earth and critical minerals at the Brook Mine are reported as in-place inferred resources. Rare earth and critical minerals is a new initiative for us and, as such, has required and will continue to require us to make significant investments to build out our rare earth capabilities.
More news about: Ramaco Resources, Inc.
Oct 30, 2025, 15:20 ET Simplicity Patterns Relaunches Under Independent, Employee-Led Management
In 2026, Simplicity will introduce highly anticipated new patterns from Gunne Sax, as well as its "Vintage Vault", carefully curating and reissuing rare pattern treasures from extensive fashion archives. "We're grateful to our entire community for their patience as we've been preparing
More news about: Simplicity Patterns Inc.
Oct 30, 2025, 15:15 ET Luxury (High End) Lighting Market to Reach USD 35,220.96 million by 2032, Growing At An 6.40% CAGR - Credence Research
often relies on a global supply chain for specialized and high-quality raw materials, from Italian marble and Murano glass to high-purity metals and rare woods. These supply chains can be complex and vulnerable to disruption from geopolitical events, trade tariffs, and logistical challenges. Any interruption
More news about: Credence Research Inc.
Oct 30, 2025, 13:52 ET RightOfTheDot to Host NamesCon Global 2025 Live & Online Domain Auction Featuring Tokens.com and Omegle.com
and authentication, making this domain ideal for a financial platform, DeFi gateway, or tokenized marketplace. Tokens·com represents a rare, universal brand perfectly aligned with the future of digital finance and Web3 innovation.
More news about: RightOfTheDot